Announcement of Funding Opportunity: Joint Canada-Israel Health Research Program Phase II – 2021-2022 competition

Canadian Institutes of Health Research (CIHR), in collaboration with the Azrieli Foundation, Canada's International Development Research Centre (IDRC), and the Israel Science Foundation (ISF) are pleased to launch the first call for proposals under the second phase of the Joint Canada-Israel Health Research Program (JCIHRP).

Phase II of JCIHRP seeks to support fundamental research at the cutting-edge of biomedical science and global health. Six grants worth CA $1.4 million each will be awarded to research teams based in Canada, Israel and low- and middle-income countries (LMICs) for a period of up to four years.

This first call for proposals under phase II is directed toward proposals at the intersection between non-communicable chronic diseases (NCDs) and infectious diseases, while strengthening research capacity in Canada, Israel and LMICs. Potential topics may include, but are not limited to the following:

• Use of epidemiological and clinical data to gain insight into biological mechanisms influencing the intersection of NCDs and infectious diseases.
• Study of mechanisms driving the interactions between NCDs and infectious diseases.
• Biomarkers and/or predictive factors of NCDs following infections or infection severity with pre-existing NCDs.
• System biology approaches.

Proposals must be co-led by three independent investigators, one from Canada, Israel and an eligible LMIC. Teams are required to establish knowledge mobilization plans. This could include a range of activities that support research, training and exchange, while taking advantage of this funding opportunity to design a collaborative international research project.

This funding opportunity is now available on ResearchNet and includes two steps: registration and application. In Canada, registrations are due March 10, 2022 and applications are due April 5, 2022.
In Israel, registrations are due March 9, 2022 and applications are due April 4, 2022.

Date modified:

2022-02-23